Display options
Share it on

Can J Infect Dis. 1991;2(1):12-8. doi: 10.1155/1991/989875.

Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses

M J Gill, R Read

Affiliations

  1. Departments of Medicine, Microbiology and Infectious Diseases, University of Calgary, Calgary, Alberta.

PMID: 22451747 PMCID: PMC3307398 DOI: 10.1155/1991/989875

Abstract

Since the first report of human infection with Pneumocystis carinii in 1942, cases of pneumonia due to this opportunistic pathogen have become increasingly common. Animal studies and clinical observations show that a significant depletion or dysfunction of T helper lymphocytes predisposes to clinical disease. Individuals with damaged T helper cells secondary to malignancies (eg, Hodgkin's lymphoma), drugs (eg, cyclosporine, steroids), or certain infections (eg, human immunodeficiency virus) are at particular risk. Serological studies suggest that disease is most often secondary to the reactivation of an asymptomatic infection, usually acquired during childhood. Increasing shortness of breath, a nonproductive cough and hypoxia often preceded by several weeks of lethargy, fever and weight loss are the classical features of P carinii pneumonia in acquired immune deficiency syndrome. Bronchoalveolar lavage is usually the optimal diagnostic test. Immunofluorescent staining on liquified sputum induced by nebulized saline appears to be a promising and noninvasive test. Early empiric therapy with trimethoprim-sulphamethoxazole (trimethoprim 5 mg-sulphamethoxazole 25 mg/kg/day every 6 h) or intravenous pentamidine (4 mg/kg/day) for 21 days is usually effective, but infection is not eradicated, and clinical disease is likely to recur. Prophylaxis using aerosolized pentamidine reduces the risk of pulmonary disease but can predispose to extrapulmonary infection. Improved in vitro and in vivo models of human pneumocystis infection would significantly increase understanding of the molecular biology of the organism, the pathogenesis of disease, and the optimal therapeutic regimens.

Keywords: Immunosuppression; Pneumocystis carinii; Pneumonia

References

  1. JAMA. 1988 Feb 26;259(8):1185-9 - PubMed
  2. Ann Intern Med. 1986 Jul;105(1):45-8 - PubMed
  3. Ann Intern Med. 1990 Aug 1;113(3):203-9 - PubMed
  4. Antimicrob Agents Chemother. 1988 May;32(5):623-5 - PubMed
  5. Lab Invest. 1966 Oct;15(10):1559-77 - PubMed
  6. Ann Intern Med. 1987 Mar;106(3):396-8 - PubMed
  7. Infect Immun. 1973 Sep;8(3):317-21 - PubMed
  8. N Engl J Med. 1990 Aug 23;323(8):531-3 - PubMed
  9. N Engl J Med. 1987 Jan 8;316(2):61-6 - PubMed
  10. Ann Intern Med. 1989 May 1;110(9):737-8 - PubMed
  11. Am Rev Respir Dis. 1984 Dec;130(6):1166-9 - PubMed
  12. Ann Intern Med. 1987 Mar;106(3):399-400 - PubMed
  13. Infect Immun. 1979 Jun;24(3):939-47 - PubMed
  14. Natl Cancer Inst Monogr. 1976 Oct;43:65-74 - PubMed
  15. Ann Intern Med. 1986 Jul;105(1):37-44 - PubMed
  16. Ann Intern Med. 1990 Aug 1;113(3):195-202 - PubMed
  17. J Immunol. 1988 Mar 15;140(6):2023-31 - PubMed
  18. N Engl J Med. 1990 Nov 22;323(21):1444-50 - PubMed
  19. AJR Am J Roentgenol. 1986 Jul;147(1):29-31 - PubMed
  20. J Infect Dis. 1990 Feb;161(2):296-306 - PubMed
  21. Ann Intern Med. 1984 May;100(5):663-71 - PubMed
  22. Am J Med. 1985 Mar;78(3):429-37 - PubMed
  23. Lancet. 1989 Jul 22;2(8656):205-6 - PubMed
  24. N Engl J Med. 1990 Sep 20;323(12):769-75 - PubMed
  25. N Engl J Med. 1982 Jul 15;307(3):184-5 - PubMed
  26. Ann Intern Med. 1974 Jan;80(1):83-93 - PubMed
  27. Am Rev Respir Dis. 1989 Jun;139(6):1336-42 - PubMed
  28. Ann Intern Med. 1987 May;106(5):714-8 - PubMed
  29. Ann Intern Med. 1991 Jun 1;114(11):948-53 - PubMed
  30. Med Clin North Am. 1974 May;58(3):649-59 - PubMed
  31. Lancet. 1989 May 13;1(8646):1046-8 - PubMed
  32. Ann Intern Med. 1990 May 15;112(10):750-7 - PubMed
  33. Zentralbl Bakteriol Orig. 1952 May 12;158(1-2):120-7 - PubMed
  34. Rev Infect Dis. 1986 Nov-Dec;8(6):1001-11 - PubMed
  35. Am J Med. 1988 Feb;84(2):303-6 - PubMed
  36. Am Rev Respir Dis. 1986 Nov;134(5):1094-6 - PubMed
  37. Curr Ther Res Clin Exp. 1973 Aug;15(8):581-7 - PubMed
  38. N Engl J Med. 1990 Nov 22;323(21):1451-7 - PubMed
  39. Ann Intern Med. 1988 Jul 1;109(1):7-10 - PubMed
  40. N Engl J Med. 1990 Jan 18;322(3):161-5 - PubMed
  41. Ann Intern Med. 1989 Oct 15;111(8):681-2 - PubMed
  42. AIDS. 1990 Oct;4(10):1019-21 - PubMed
  43. N Engl J Med. 1990 Sep 20;323(12):776-82 - PubMed
  44. Jpn J Exp Med. 1984 Apr;54(2):57-64 - PubMed
  45. Ann Intern Med. 1990 Jul 1;113(1):14-20 - PubMed
  46. N Engl J Med. 1990 Nov 22;323(21):1500-4 - PubMed
  47. Medicine (Baltimore). 1973 Jan;52(1):23-51 - PubMed
  48. Ann Intern Med. 1989 Nov 15;111(10):813-26 - PubMed
  49. J Clin Microbiol. 1985 Dec;22(6):1058-60 - PubMed
  50. Am Rev Respir Dis. 1987 Nov;136(5):1199-206 - PubMed
  51. J Infect Dis. 1988 Jun;157(6):1115-9 - PubMed
  52. Antimicrob Agents Chemother. 1990 Apr;34(4):499-504 - PubMed
  53. N Engl J Med. 1987 Oct 15;317(16):978-85 - PubMed
  54. Science. 1977 Jul 8;197(4299):177-9 - PubMed
  55. Nature. 1988 Aug 11;334(6182):519-22 - PubMed
  56. N Engl J Med. 1984 Jun 21;310(25):1682-8 - PubMed
  57. N Engl J Med. 1988 Mar 10;318(10):589-93 - PubMed
  58. MMWR Suppl. 1989 Jun 16;38(5):1-9 - PubMed
  59. Ann Intern Med. 1988 Aug 15;109(4):280-7 - PubMed

Publication Types